Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3773 | 1912 | 49.8 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
180 | 3 | DUCHENNE MUSCULAR DYSTROPHY//DYSTROPHIN//MUSCULAR DYSTROPHY | 56784 |
991 | 2 | DUCHENNE MUSCULAR DYSTROPHY//DYSTROPHIN//MUSCULAR DYSTROPHY | 10483 |
3773 | 1 | MDX MOUSE//DUCHENNE MUSCULAR DYSTROPHY//MDX | 1912 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MDX MOUSE | authKW | 1413001 | 8% | 57% | 156 |
2 | DUCHENNE MUSCULAR DYSTROPHY | authKW | 1313889 | 20% | 21% | 383 |
3 | MDX | authKW | 1283304 | 8% | 56% | 144 |
4 | MUSCULAR DYSTROPHY | authKW | 846720 | 16% | 17% | 308 |
5 | DYSTROPHIN | authKW | 745900 | 13% | 19% | 248 |
6 | MDX MICE | authKW | 614715 | 4% | 50% | 77 |
7 | UTROPHIN | authKW | 360223 | 4% | 33% | 69 |
8 | GENEVA LAUSANNE PHARMACEUT SCI | address | 156204 | 1% | 65% | 15 |
9 | DMD | authKW | 147788 | 3% | 18% | 52 |
10 | GOLDEN RETRIEVER MUSCULAR DYSTROPHY | authKW | 142028 | 1% | 68% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 5514 | 24% | 0% | 463 |
2 | Neurosciences | 4125 | 28% | 0% | 542 |
3 | Cell Biology | 3085 | 22% | 0% | 417 |
4 | Physiology | 2471 | 13% | 0% | 251 |
5 | Genetics & Heredity | 1074 | 11% | 0% | 212 |
6 | Medicine, Research & Experimental | 1015 | 10% | 0% | 184 |
7 | Biochemistry & Molecular Biology | 939 | 22% | 0% | 420 |
8 | Pathology | 820 | 6% | 0% | 124 |
9 | Sport Sciences | 173 | 3% | 0% | 52 |
10 | Multidisciplinary Sciences | 134 | 2% | 0% | 32 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENEVA LAUSANNE PHARMACEUT SCI | 156204 | 1% | 65% | 15 |
2 | UCL 5540 | 79843 | 0% | 100% | 5 |
3 | SENATOR PAUL D WELLSTONE MUSCULAR DYSTROPHY COOPE | 71001 | 1% | 34% | 13 |
4 | MOL CELLULAR INTEGRAT PHYSIOL PROGRAM | 69666 | 1% | 36% | 12 |
5 | CGMC | 68109 | 1% | 27% | 16 |
6 | MUSCULAR PATHOL UNIT | 63874 | 0% | 100% | 4 |
7 | UPR NEUROBIOL | 52255 | 0% | 55% | 6 |
8 | DUCHENNE MUSCULAR DYSTROPHY | 43897 | 1% | 25% | 11 |
9 | BASIC CLIN MYOL | 36798 | 1% | 16% | 14 |
10 | UNIT CLIN PHARMACOL COUNCIL NEUROSC | 35928 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROMUSCULAR DISORDERS | 125534 | 7% | 6% | 136 |
2 | MUSCLE & NERVE | 41676 | 7% | 2% | 136 |
3 | SKELETAL MUSCLE | 18589 | 1% | 8% | 15 |
4 | HUMAN MOLECULAR GENETICS | 13762 | 5% | 1% | 92 |
5 | JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY | 8824 | 2% | 2% | 30 |
6 | JOURNAL OF THE NEUROLOGICAL SCIENCES | 4043 | 3% | 1% | 51 |
7 | AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 3153 | 2% | 1% | 38 |
8 | MOLECULAR THERAPY | 2773 | 1% | 1% | 25 |
9 | AMERICAN JOURNAL OF PATHOLOGY | 2492 | 2% | 0% | 45 |
10 | FASEB JOURNAL | 1998 | 2% | 0% | 35 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MDX MOUSE | 1413001 | 8% | 57% | 156 | Search MDX+MOUSE | Search MDX+MOUSE |
2 | DUCHENNE MUSCULAR DYSTROPHY | 1313889 | 20% | 21% | 383 | Search DUCHENNE+MUSCULAR+DYSTROPHY | Search DUCHENNE+MUSCULAR+DYSTROPHY |
3 | MDX | 1283304 | 8% | 56% | 144 | Search MDX | Search MDX |
4 | MUSCULAR DYSTROPHY | 846720 | 16% | 17% | 308 | Search MUSCULAR+DYSTROPHY | Search MUSCULAR+DYSTROPHY |
5 | DYSTROPHIN | 745900 | 13% | 19% | 248 | Search DYSTROPHIN | Search DYSTROPHIN |
6 | MDX MICE | 614715 | 4% | 50% | 77 | Search MDX+MICE | Search MDX+MICE |
7 | UTROPHIN | 360223 | 4% | 33% | 69 | Search UTROPHIN | Search UTROPHIN |
8 | DMD | 147788 | 3% | 18% | 52 | Search DMD | Search DMD |
9 | GOLDEN RETRIEVER MUSCULAR DYSTROPHY | 142028 | 1% | 68% | 13 | Search GOLDEN+RETRIEVER+MUSCULAR+DYSTROPHY | Search GOLDEN+RETRIEVER+MUSCULAR+DYSTROPHY |
10 | MYOFIBRE NECROSIS | 79843 | 0% | 100% | 5 | Search MYOFIBRE+NECROSIS | Search MYOFIBRE+NECROSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ALLEN, DG , WHITEHEAD, NP , FROEHNER, SC , (2016) ABSENCE OF DYSTROPHIN DISRUPTS SKELETAL MUSCLE SIGNALING: ROLES OF CA2+, REACTIVE OXYGEN SPECIES, AND NITRIC OXIDE IN THE DEVELOPMENT OF MUSCULAR DYSTROPHY.PHYSIOLOGICAL REVIEWS. VOL. 96. ISSUE 1. P. 253 -305 | 185 | 37% | 7 |
2 | FAIRCLOUGH, RJ , PERKINS, KJ , DAVIES, KE , (2012) PHARMACOLOGICALLY TARGETING THE PRIMARY DEFECT AND DOWNSTREAM PATHOLOGY IN DUCHENNE MUSCULAR DYSTROPHY.CURRENT GENE THERAPY. VOL. 12. ISSUE 3. P. 206 -244 | 218 | 41% | 20 |
3 | KORNEGAY, JN , SPURNEY, CF , NGHIEM, PP , BRINKMEYER-LANGFORD, CL , HOFFMAN, EP , NAGARAJU, K , (2014) PHARMACOLOGIC MANAGEMENT OF DUCHENNE MUSCULAR DYSTROPHY: TARGET IDENTIFICATION AND PRECLINICAL TRIALS.ILAR JOURNAL. VOL. 55. ISSUE 1. P. 119 -149 | 161 | 51% | 10 |
4 | MCGREEVY, JW , HAKIM, CH , MCINTOSH, MA , DUAN, DS , (2015) ANIMAL MODELS OF DUCHENNE MUSCULAR DYSTROPHY: FROM BASIC MECHANISMS TO GENE THERAPY.DISEASE MODELS & MECHANISMS. VOL. 8. ISSUE 3. P. 195 -213 | 129 | 41% | 30 |
5 | MOSQUEIRA, M , ZEIGER, U , FORDERER, M , BRINKMEIER, H , FINK, RHA , (2013) CARDIAC AND RESPIRATORY DYSFUNCTION IN DUCHENNE MUSCULAR DYSTROPHY AND THE ROLE OF SECOND MESSENGERS.MEDICINAL RESEARCH REVIEWS. VOL. 33. ISSUE 5. P. 1174-1213 | 149 | 46% | 16 |
6 | SHIN, J , TAJRISHI, MM , OGURA, Y , KUMAR, A , (2013) WASTING MECHANISMS IN MUSCULAR DYSTROPHY.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 45. ISSUE 10. P. 2266-2279 | 104 | 50% | 26 |
7 | SPINAZZOLA, JM , KUNKEL, LM , (2016) PHARMACOLOGICAL THERAPEUTICS TARGETING THE SECONDARY DEFECTS AND DOWNSTREAM PATHOLOGY OF DUCHENNE MUSCULAR DYSTROPHY.EXPERT OPINION ON ORPHAN DRUGS. VOL. 4. ISSUE 11. P. 1179 -1194 | 98 | 57% | 0 |
8 | GROUNDS, MD , RADLEY, HG , LYNCH, GS , NAGARAJU, K , DE LUCA, A , (2008) TOWARDS DEVELOPING STANDARD OPERATING PROCEDURES FOR PRE-CLINICAL TESTING IN THE MDX MOUSE MODEL OF DUCHENNE MUSCULAR DYSTROPHY.NEUROBIOLOGY OF DISEASE. VOL. 31. ISSUE 1. P. 1 -19 | 100 | 54% | 107 |
9 | KIM, JH , KWAK, HB , THOMPSON, LV , LAWLER, JM , (2013) CONTRIBUTION OF OXIDATIVE STRESS TO PATHOLOGY IN DIAPHRAGM AND LIMB MUSCLES WITH DUCHENNE MUSCULAR DYSTROPHY.JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY. VOL. 34. ISSUE 1. P. 1 -13 | 76 | 67% | 20 |
10 | WILLMANN, R , POSSEKEL, S , DUBACH-POWELL, J , MEIER, T , RUEGG, MA , (2009) MAMMALIAN ANIMAL MODELS FOR DUCHENNE MUSCULAR DYSTROPHY.NEUROMUSCULAR DISORDERS. VOL. 19. ISSUE 4. P. 241-249 | 64 | 80% | 76 |
Classes with closest relation at Level 1 |